Biography and Research Information
OverviewAI-generated summary
Kayla Hefner's research has explored diverse biological topics, including the identification of olfactory receptors in insects and considerations for managing adverse events associated with talquetamab in multiple myeloma patients. Her work on talquetamab, a therapeutic agent, highlights a focus on pharmacological effects and toxicity in cancer treatment. In parallel, her investigation into olfactory receptors in the pole borer, Neandra brunnea, indicates an interest in insect sensory biology and its underlying molecular mechanisms. Hefner has one publication with collaborator Stephanie Rogers, also at the University of Arkansas for Medical Sciences. Her scholarly output to date includes two publications and has garnered five citations, with an h-index of 1.
Metrics
- h-index: 1
- Publications: 2
- Citations: 5
Selected Publications
-
Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma (2024)
Collaboration Network
Top Collaborators
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
- Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Similar Researchers
Based on overlapping research topics